Search Results - "Capala, J"

415 Investigating the Role of HER4 in Relation to Trastuzumab Treatment and Resistance in HER2 Positive Breast Cancer by Nafi, S. Mohd, Kong, A, Gijsen, M, Kramer-Marek, G, Capala, J

Get full text

An international dosimetry exchange for boron neutron capture therapy, Part I: Absorbed dose measurements by Binns, P. J., Riley, K. J., Harling, O. K., Kiger, W. S., Munck af Rosenschöld, P. M., Giusti, V., Capala, J., Sköld, K., Auterinen, I., Serén, T., Kotiluoto, P., Uusi-Simola, J., Marek, M., Viererbl, L., Spurny, F.

“…An international collaboration was organized to undertake a dosimetry exchange to enable the future combination of clinical data from different centers…”
Get full text

Image Guided, Motion-free Patient Body Setup using 3D Volumetric Image Registration of Classified Stable Bony Landmarks by Li, G, Ning, H, Brown, A, Citrin, D, Xie, H, Chang, J, Arora, B, Capala, J, Camphausen, K, Miller, R.W

Get full text

A Pancreas Motion Study Using Automatic Image Segmentation of Time-Resolved, Single-Slice MR Images by Li, G, Guion, P, Ning, H, Citrin, D, Xie, H, Capala, J, Arora, B.C, Camphausen, K, Singh, A.K, Miller, R.W

Get full text

Use of an Optical Fiber Dosimeter to Measure Small Field Output Factors in Stereotactic Radiosurgery by Miller, R.W, Ning, H, Justus, B, Huston, A, Li, G, Chang, J, Capala, J, Xie, H, Citrin, D, Camphausen, K

Get full text

710 Sarcosine induces up-regulation of HER2/neu in androgen dependent prostate cancer cells by Dahl, M, Bouchelouche, P, Kramer-Marek, G, Capala, J, Nordling, J, Bouchelouche, K

Get full text

715 Effect of tumour necrosis factor (TNF) alpha on HER2/neu expression in ovarian cancer cells by Dahl, M, Bouchelouche, P, Kramer-Marek, G, Capala, J, Bouchelouche, K

Get full text

SU‐FF‐J‐74: High Accuracy of Volumetric Image Registration of CT, MR and PET Images by Li, G, Xie, H, Ning, H, Citrin, D, Capala, J, Arora, B, Coleman, C, Camphausen, K, Miller, R

“…Purpose: To test the accuracy of the 3D volumetric image registration technique, the registration has been evaluated against “co‐registered” CT phantom images,…”
Get full text

Reference dosimetry at the neutron capture therapy facility at Studsvik by Munck af Rosenschöld, P. M., Giusti, V., Ceberg, C. P., Capala, J., Sköld, K., Persson, B. R. R.

“…The purpose of this publication was to present and evaluate the methods for reference dosimetry in the epithermal neutron beam at the neutron capture therapy…”
Get full text

Boron neutron capture therapy (BNCT): Implications of neutron beam and boron compound characteristics by Wheeler, Floyd J., Nigg, David W., Capala, Jacek, Watkins, Peter R. D., Vroegindeweij, Corine, Auterinen, Iiro, Seppälä, Tiina, Bleuel, Darren

“…The potential efficacy of boron neutron capture therapy (BNCT) for malignant glioma is a significant function of epithermal-neutron beam biophysical…”
Get full text

Evaluation of systemically administered radiolabeled epidermal growth factor as a brain tumor targeting agent by YANG, Weilian, BARTH, Rolf F, LEVEILLE, Renee, ADAMS, Dianne M, CIESIELSKI, Michael, FENSTERMAKER, Robert A, CAPALA, Jacek

“…We have previously reported a method for labeling epidermal growth factor (EGF) with technetium-99m and have shown that 99mTc-EGF localized in EGF receptor (R)…”
Get full text

An improved neutron collimator for brain tumor irradiations in clinical boron neutron capture therapy by Liu, H B, Greenberg, D D, Capala, J, Wheeler, F J

“…To improve beam penetration into a head allowing the treatment of deeper seated tumors, two neutron collimators were built sequentially and tested for use in…”
Get more information

Current Status of Radiation Oncology Research funded through the National Cancer Institute’s Small Business Innovation Research Program by Zakeri, K., Narayanan, D., Capala, J., Prasanna, P.G., Buchsbaum, J., Evans, G., Weingarten, M., Coleman, C.N.N., Vikram, B.

Get full text

Cosmic ray hit frequencies in critical sites in the central nervous system by Curtis, S.B., Vazquez, M.E., Wilson, J.W., Atwell, W., Kim, M., Capala, J.

“…One outstanding question to be addressed in assessing the risk of exposure to space travelers from galactic cosmic rays (GCR) outside the geomagnetosphere is…”
Get full text

Uptake, toxicity and radiation effects of the boron compounds DAAC-1 and DAC-1 in cultured human glioma cells by OLSSON, P., BLACK, M, CAPALA, J, CODERRE, J, HARTMAN, T, MAKAR, M, MALMQUIST, J, PETTERSSON, M, TILLY, N, SJOEBERG, S, CARLSSON, J

“…Purpose: To study the uptake, toxicity and radiation effects in vitro of a diol-amino acid-carborane (DAAC-1) and make comparisons with the previously studied…”
Get full text

Central nervous system tolerance to boron neutron capture therapy with p-boronophenylalanine by MORRIS, G. M, CODERRE, J. A, MICCA, P. L, FISHER, C. D, CAPALA, J, HOPEWELL, J. W

“…A rat spinal cord model was used to evaluate the effects of boron neutron capture irradiation on the central nervous system (CNS), using a range of doses of…”
Get full text

Tolerance of the normal canine brain to epithermal neutron irradiation in the presence of p-boronophenylalanine by CODERRE, Jeffrey A, GAVIN, Patrick R, CAPALA, Jacek, RUIMEI MA, MORRIS, Gerard M, BUTTON, Terry M, AZIZ, Tariq, PERESS, Nancy S

“…Twelve normal dogs underwent brain irradiation in a mixed-radiation, mainly epithermal neutron field at the Brookhaven Medical Research Reactor following…”
Get full text

Influence of chloroquine and lidocaine on retention and cytotoxic effects of [131I]EGF: studies on cultured glioma cells by Capala, J, Carlsson, J

“…Targeting of toxic substances to the epidermal growth factor, EGF, receptor might be an attractive therapeutic approach because of the increased…”
Get more information

Quantitative Analysis of HER2 Receptors Expression In Vivo by Near-Infrared Optical Imaging by Capala, J., Chernomordik, V., Hassan, M., Zielinski, R., Gandjbakhche, A.

“…Purpose: HER2 overexpression has been associated with a poor prognosis and resistance to therapy in breast cancer patients. However, up to now, quantitative…”
Get full text

Affitoxin: A Novel Recombinant, HER2-specific, Anticancer Agent for Targeted Therapy of HER2-positive Tumors by ZIELINSKI, Rafal, LYAKHOV, Ilya, JACOBS, Amy, CHERTOV, Oleg, KRAMER-MAREK, Gabriela, FRANCELLA, Nicholas, STEPHEN, Andrew, FISHER, Robert, BLUMENTHAL, Robert, CAPALA, Jacek

“…Expression of the human epidermal growth factor receptor 2 (HER2) is amplified in 25% to 30% of breast cancers and has been associated with an unfavorable…”
Get full text